Biochemotherapy for melanoma : Rational therapeutics in the search for weapons of melanoma destruction
β Scribed by Kim A. Margolin
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 60 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Understanding of the mechanisms underlying the activity and limitations of biochemotherapy remains inadequate. The design of new regimens should based on emerging knowledge regarding molecular mechanisms of oncogenesis, cancer cell proliferation and survival, and control apoptosis.
See also pages 596β603.
π SIMILAR VOLUMES
We evaluated the efficacy of a candidate melanoma vaccine approach in mice genetically prone to develop melanoma due to the introduction of an oncogenic mutation (R24C) in the germline sequence of the cyclin-dependent kinase 4 (cdk4), a protein critically involved in cell cycle regulation. Melanomas
During the process of oncogenic transformation, melanoma cells escape from normal growth-control mechanisms and acquire the ability to invade surrounding tissues and organs. The Ras/Raf/MEK/ERK pathway is a major pathway involved in the control of growth signals, cell survival and invasion. Melanoma
Fine-needle aspiration (FNA) has been used as a fast, minimally invasive, and reliable method for the evaluation of enlarged lymph nodes. However, there are some cases where the definitive diagnosis cannot be elicited with morphology alone, especially cases without a known primary lesion. Although i
One hundred forty patients affected by high risk or locally advanced melanoma of the extremities were submitted to hyperthermic perfusion in extracorporeal circulation at the National Cancer Institute of Milan, Italy. Using adequate temperature and drug dosage, we increased survival of stage IIIA pa